Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingning Maru (also known as Qingning Wan) is a traditional Chinese medicine (TCM) formulated as water-honey pills, developed and manufactured by Zhejiang Tianyitang Pharmaceutical. It is prepared from a complex mixture of botanical ingredients, including rhubarb (Rhei Radix et Rhizoma), mung bean, plantain herb, stir-baked Atractylodes macrocephala, black soybean, processed Pinellia, vinegar-processed Cyperus rotundus, mulberry leaf, peach twig, cow milk, ginger-processed Magnolia bark, malted barley, tangerine peel, and Platycladus orientalis leaf. Qingning Maru is approved in China for clearing heat, purging fire, reducing swelling, and relaxing the bowels. It is primarily indicated for the treatment of constipation, abdominal distension, sore throat, mouth and tongue sores, dizziness, tinnitus, red eyes, and toothache caused by the internal accumulation of fire-toxin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingning Maru.